For international biotechnology companies advancing toward commercialization, F³ Tech offers a practical pathway to establish a U.S. manufacturing presence — scaling production capability and building market access simultaneously.
Establishing a U.S. Presence
For international biotechnology companies, establishing a U.S. presence traditionally requires a choice between market development and manufacturing buildout — two capital-intensive processes that are difficult to pursue in parallel. F³ Tech changes that dynamic.
By providing access to a fully equipped pilot-scale biomanufacturing facility on the U.S. East Coast, F³ Tech enables international companies to conduct U.S.-based production operations, generate data for regulatory submissions, and engage directly with U.S. customers, partners, and investors — without the capital requirements of building or leasing a dedicated facility.
This is not a relocation program. It is a manufacturing platform that allows companies to scale their production capability and establish their U.S. market presence simultaneously — reducing both time and capital required for U.S. market entry.
Conduct pilot-scale production runs in a U.S. facility, generating U.S.-manufactured product for regulatory, partner, and customer purposes.
Generate U.S. process and analytical data aligned with EPA, USDA, or FDA requirements for agricultural and bioindustrial products.
Engage directly with U.S. agricultural companies, chemical manufacturers, distributors, and industry partners from a U.S. operational base.
Gain visibility with U.S.-based investors and strategic partners who are more accessible from a domestic operational presence.
Strategic Location Advantages
Direct access to USDA, EPA, FDA, DARPA, and other federal agencies within 90 minutes — essential for companies navigating U.S. regulatory pathways.
Within 4 hours of the major Mid-Atlantic and Northeast markets, including Philadelphia, New York, Baltimore, and Boston — home to major agriculture, chemical, and biotech industries.
Significantly lower facility, labor, and operational costs relative to major biotech hubs in Boston, San Francisco, or Research Triangle — extending capital efficiency at the scale-up stage.
Direct access to Eastern Shore agricultural supply chains, enabling U.S. feedstock sourcing for companies whose production processes depend on agricultural raw materials.
Access to U.S. Markets and Partners
F³ Tech’s established relationships with U.S. industry partners, regulatory contacts, and regional supply chain participants give international companies a meaningful head start in navigating the U.S. market. Rather than building these connections from scratch, F³ Tech program participants can leverage an existing network developed over years of operating at the center of the Eastern Shore bioindustrial ecosystem.
For companies in agricultural biologicals, industrial fermentation, novel biomaterials, and environmental biotechnology, the U.S. market represents the largest single destination for their technologies. F³ Tech provides the operational foothold from which that market can be approached with a credible, data-backed U.S. manufacturing story.
Ideal Company Profile
F³ Tech’s U.S. Market Access program is designed for companies that are beyond early-stage research and actively advancing toward commercial production. The ideal participant has a validated technology, a defined target market, and a clear need for U.S.-based manufacturing capability or market presence.
